Jeff Ervin, MBA
Chief Executive Officer
Jeff carries a proven track record for administration, leadership, and finance. He has a distinguished career, holding positions such as Senior Financial Analyst for the Baptist Hospital System of Nashville, Senior Financial Officer for Medicare.com, and Co-Founder, President and CEO of IMAC Holdings, a company he took public in 2019.
Douglas Oliver, MSW
Chief Operations Officer
Doug has an extensive 20-year career in that field of medical social work, gerontology, and healthcare policy compliance. In 2019, he was awarded a Regenerative Medicine and Stem Cell Action Award For Inspiration at the World Stem Cell Summit. He is described as a "Patient Ambassador", seeking to elevate the Patient Position in direct drug development roles.
Anthony Oliva, PhD
Chief Scientific Director
Anthony is a nationally-recognized leader in neurosciences, specializing in neurodegenerative diseases and aging. He has served as an assistant professor at the Herbert Wertheim College of Medicine at Florida International University, and as a senior scientist at Longeveron, leading clinical programs in Alzheimer’s disease, Aging Frailty, and other indications.
Copyright © 2025 | Sanaregen™ Vision Therapeutics, Inc. | All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.